newsfilter
← Latest News
GlobeNewswire·

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Preliminary, unaudited revenue for the full year 2024 of approximately $174 million Presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16th, 2024, at 9:45 a.m. PT. SOUTH SAN